In hepatocellular carcinoma, it was proven that the upregulation of the Nrf2 signaling pathway was correlated with the increased level of MMP9 (matrix metallopeptidase 9) and Bcl-xL (B-cell lymphoma extra large). The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.